Search research articles
Contact Us
Filters
Showing results (151-160 of 160) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 160 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Copy number alterations assessed at the single-cell level revealed mono- and polyclonal seeding patterns of distant metastasis in a small-cell lung cancer patient
P Ferronika, H van den Bos, A Taudt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 13, 2012
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
T J N Hiltermann, M M Pore, A van den Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2017
Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer
A J van der Wekken, R Pelgrim, N 't Hart, et al.
Allergy
|
July 21, 2016
Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma
M A Nieuwenhuis, M Siedlinski, M van den Berge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 5, 2021
<sup>89</sup>Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer
I C Kok, J S Hooiveld, P P van de Donk, et al.
ESMO Open
|
November 5, 2024
Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy
V D de Jager, P Plomp, M S Paats, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
Determinants of SARS-CoV-2 receptor gene expression in upper and lower airways
H Aliee, F Massip, C Qi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
J W T van der Wel, S M Ernst, M Jebbink, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 21, 2019
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
E Thunnissen, B I Lissenberg-Witte, M M van den Heuvel, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 160) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 160 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Copy number alterations assessed at the single-cell level revealed mono- and polyclonal seeding patterns of distant metastasis in a small-cell lung cancer patient
P Ferronika, H van den Bos, A Taudt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 13, 2012
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
T J N Hiltermann, M M Pore, A van den Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2017
Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer
A J van der Wekken, R Pelgrim, N 't Hart, et al.
Allergy
|
July 21, 2016
Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma
M A Nieuwenhuis, M Siedlinski, M van den Berge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 5, 2021
<sup>89</sup>Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer
I C Kok, J S Hooiveld, P P van de Donk, et al.
ESMO Open
|
November 5, 2024
Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy
V D de Jager, P Plomp, M S Paats, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
Determinants of SARS-CoV-2 receptor gene expression in upper and lower airways
H Aliee, F Massip, C Qi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
J W T van der Wel, S M Ernst, M Jebbink, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 21, 2019
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
E Thunnissen, B I Lissenberg-Witte, M M van den Heuvel, et al.
ESMO Open
|
January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
P Hofman, M Ilié, E Chamorey, et al.
Page
of 16